5 Best Small Cap Pharma Stocks to Buy

2. Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Number of Hedge Fund Investors in Q1 2023: 25

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) develops treatments for severe pain and sells products that target long term pain and constipation. It is another stock that is rated Stock Buy on average, and the shares offer a $12 upside.

After digging through 943 hedge funds for this year’s first quarter, Insider Monkey discovered that 25 had bought the firm’s shares. Out of these, the firm’s largest shareholder is David Rosen’s Rubric Capital Management since it owns a $78 million stake.

Follow Collegium Pharmaceutical Inc